APA (7th ed.) Citation

A, C., M, G., V, C., L, L., M, P., A, B., . . . A, A. (2026). Comparative treatment persistence of upadacitinib vs. tofacitinib in psoriatic arthritis: A multicenter observational study from the BIRRA cohort. Frontiers in medicine, 13, 1813319. https://doi.org/10.3389/fmed.2026.1813319

Chicago Style (17th ed.) Citation

A, Conforti, et al. "Comparative Treatment Persistence of Upadacitinib Vs. Tofacitinib in Psoriatic Arthritis: A Multicenter Observational Study from the BIRRA Cohort." Frontiers in Medicine 13 (2026): 1813319. https://doi.org/10.3389/fmed.2026.1813319.

MLA (9th ed.) Citation

A, Conforti, et al. "Comparative Treatment Persistence of Upadacitinib Vs. Tofacitinib in Psoriatic Arthritis: A Multicenter Observational Study from the BIRRA Cohort." Frontiers in Medicine, vol. 13, 2026, p. 1813319, https://doi.org/10.3389/fmed.2026.1813319.